These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 36584257

  • 21. Leukopenia in clozapine treated patients may be induced by other drugs: a case series.
    Imbarlina MJ, Sarkar S, Marwah S, Parepally H, Johnston PR, Brar JS, Chengappa KN.
    Eur Psychiatry; 2004 Dec; 19(8):506-9. PubMed ID: 15589712
    [Abstract] [Full Text] [Related]

  • 22. [Granulocytopenia while using clozapine: continuing or stopping treatment].
    Bogers JP.
    Tijdschr Psychiatr; 2007 Dec; 49(8):575-9. PubMed ID: 17694491
    [Abstract] [Full Text] [Related]

  • 23. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D.
    Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
    [Abstract] [Full Text] [Related]

  • 24. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I, Bezchlibnyk-Butler K, Wong L.
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [Abstract] [Full Text] [Related]

  • 25. Chronic benign neutropenia/agranulocytosis associated with non-clozapine antipsychotics.
    Vila-Rodriguez F, Tsang P, Barr AM.
    Am J Psychiatry; 2013 Oct; 170(10):1213-4. PubMed ID: 24084822
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ, Cho MJ, Oh JT, Lee Y, Chae BJ, Ko J.
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [Abstract] [Full Text] [Related]

  • 28. Paradoxical pattern of haematological risk with clozapine.
    Gillman K.
    Br J Psychiatry; 2000 Jul; 177():88. PubMed ID: 10945101
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Haematological side effects of clozapine: patient characteristics.
    Miller PR, Cutten AE.
    N Z Med J; 1997 Apr 11; 110(1041):125-7. PubMed ID: 9140414
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Morning pseudoneutropenia during clozapine treatment.
    Esposito D, Aouillé J, Rouillon F, Limosin F.
    World J Biol Psychiatry; 2003 Oct 11; 4(4):192-4. PubMed ID: 14608591
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective.
    Legge SE, Walters JT.
    Pharmacogenomics; 2019 Mar 11; 20(4):279-290. PubMed ID: 30767710
    [Abstract] [Full Text] [Related]

  • 38. A case of clozapine induced agranulocytosis 25 years after starting treatment: Effective use of lithium for augmentation in rechallenge.
    Martina AC, Ee JS, Lamberti JS.
    Schizophr Res; 2019 Aug 11; 210():308-309. PubMed ID: 31277977
    [No Abstract] [Full Text] [Related]

  • 39. Reversible neutropenia with olanzapine following clozapine-induced neutropenia.
    Thangadurai P, Jyothi KS, Gopalakrishnan R, Kuruvilla A, Jacob KS.
    Am J Psychiatry; 2006 Jul 11; 163(7):1298. PubMed ID: 16816247
    [No Abstract] [Full Text] [Related]

  • 40. Adjunctive use of lithium carbonate for the management of neutropenia in clozapine-treated children.
    Mattai A, Fung L, Bakalar J, Overman G, Tossell J, Miller R, Rapoport J, Gogtay N.
    Hum Psychopharmacol; 2009 Oct 11; 24(7):584-9. PubMed ID: 19743394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.